Search results
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
The Independent via Yahoo News· 5 days agoAstraZeneca is withdrawing its Covid-19 vaccine worldwide, months after the pharma giant admitted...
New COVID-19 subvariant group 'FLiRT' is now dominant in Canada. What to know about symptoms, ...
Yahoo Canada Style· 3 days ago(Image via Getty) Thanasis via Getty Images While the current COVID-19 vaccine targets the XBB 1.5...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 40 minutes agoNovavax signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a...
The Silence Around Covid Vaccine Injuries
The Intercept· 17 minutes agoThis week on Deconstructed, Wightman shares his story with Ryan Grim. Days after receiving an AstraZeneca Covid-19 vaccine in 2021, Wightman ...
AstraZeneca pulls Covid vaccine after admitting rare side effect
Daily Express· 6 days agoThe Oxford-AstraZeneca Covid vaccine is set to be withdrawn after the pharmaceutical giant admitted...
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 1 day ago(NEXSTAR) — There are two new COVID-19 variants circulating, posing a threat to a summer surge. The...
Are new COVID ‘FLiRT’ variants spreading in NC? What to know about symptoms, treatment
Charlotte Observer via Yahoo News· 2 hours agoHowever, the CDC still recommends all people aged 6 months and older receive a fall COVID-19 vaccine...
AstraZeneca Withdraws Covid-19 Vaccine, Citing Lack of Demand
Bloomberg· 5 days agoAstraZeneca Plc pulled its Covid-19 vaccine from the market due to lack of demand for a shot that...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 4 days agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
Company News For May 13, 2024
Zacks via Yahoo Finance· 3 hours agoNovavax, Inc. (NVAX) shares surged 98.7% after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu vaccine ...
